A newly identified molecule called OLE helped restore the brain’s immune cells to a more protective state in Alzheimer’s ...

Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged ...

For many, it’s the ultimate dream – one which, with an exciting and controversial new gene therapy, is about to be put to the ...

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer—and identified a promising strategy to overcome that resistance.

Reprogram Biosciences, a preclinical oncology biotechnology company developing mRNA-based therapeutics to treat solid tumors, today announced the close of its seed financing. The close brings total ...

Cell therapy, particularly using cardiomyocytes, shows significant promise for treating heart failure. Direct reprogramming of somatic cells into cardiomyocytes using small molecules is advantageous ...

In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...

Leuven, 11 March 2025 – Solid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of T cells, scientists at the VIB-KU Leuven Center ...

Washington DC [US], June 19 (ANI): A newly discovered molecule, OLE, restored the brain’s immune cells to a more protective state in Alzheimer’s disease models. The treatment reduced the accumulation ...